Research What we do and how? Teams Meet our people News What's happening Photogallery Be in the picture Our Partners Join our projects Contacts Addresses, emails, phones…
Research Research
Laboratory Instruments Instruments purchased through European Regional Development Fund. CZ.02.1.01/0.0/0.0/15_003/0000495
Publications Articles published under the Project FIT
Patents And Inventions Patents filed under Project FIT
Teams Teams
Virology doc.RNDr. Daniel RŮŽEK, Ph.D.
Chemistry And Toxicology RNDr. Miroslav MACHALA, CSc.
Biotechnology and Immunology UPOL Prof. MUDr. Mgr. Milan RAŠKA, Ph.D.
News News
International Symposium - Innovative Health Care Technologies in Chemistry and Virology International Symposium​“Innovative Health Care Technologies in Chemistry and Virology”took place on 27.5.2019 at Veterinary Research Institute Brno, Czech Republic
Photogallery Photogallery
Laboratories and VRI campus Place for our scientists
Laboratory Instruments These instruments were financed by Regional Development Fund. CZ.02.1.01/0.0/0.0/15_003/0000495
Events photos Conferences, seminars, visits ...
You are here:
  • Home 
  • Teams 
  • Pharmacology And Immunotherapy

Pharmacology and Immunotherapy Group

  • Recombinant vaccines & adjuvants
  • Nanotechnology & biotechnology
  • Biopolymer & nanoparticle characterisation
  • In vitro immunological & animal models

Department of Pharmacology and Immunotherapy is lead by Dr. Josef Mašek. The department aim is recombinant vaccines and molecular adjuvans in colaboration with Institute of Organic Chemistry and Biochemistry of AS CR; Palacky University, Olomouc; Institute of Physics AS CR); such foreign universities as Imperial College London and King´s College London) and Czech pharmaceutical companies such as Bioveta, a.s.

The result of this collaboration are publications in leading scientific journals, granted patents for new molecular adjuvants, nanoliposomal carriers for vaccine delivery, and a recombinant vaccine against borreliosis for veterinary use which is currently being developed. The Department´s researchers focus on the preparation, characterisation and application of new biocompatible nanomaterials for construction of recombinant and DNA vaccines, targeted therapeutics (antivirotics, cytostatics) and contrast agents for whole body imaging.
At the forefront of research interest is the development of systems for non-invasive vaccination (e.g. mucosal sublingual vaccination). These procedures represent one of the most recent trends in the development of safe and highly efficient vaccines for veterinary and human applications. Prominent foreign institutions have shown interest in the project dealing with the development of these systems and joint research projects have been prepared.
In collaboration with the Department of Virology, one of the novel targets is also development of pharmaceutical drugs and recombinant marker vaccines against Aujeszky’s disease, which can be transmitted from overabundant wild boar populations to hunting dogs and farm pigs.
In collaboration with the Department of Chemistry and Toxicology, testing of safety and biocompatibility of new nanomaterials is carried out under the new project of the Centre of Excellence for Nanotoxicology CENATOX. If a subsidy is granted to the Department under OP R&D&I in order to accomplish the instrumental infrastructure, a cutting-edge workplace for nanopharmacology, nanotoxicology and immunotherapy will be established at the VRI.